DexCom, Inc.NASDAQ: DXCM

Dexcom Schedules Third Quarter 2026 Earnings Release and Conference Call for October 29, 2026 at 4: 30 p.m. Eastern Time

· Issued by DexCom, Inc. via Business Wire

Summary by 6ix AI

DexCom, Inc., a maker of glucose biosensing technology used to manage diabetes, plans to release its third quarter 2026 financial results after market close on Thursday, October 29, 2026. Management will hold a conference call to review the quarter starting at 4:30 p.m. (Eastern Time) the same day.

Key details

  • The call will be webcast at the same time, with the webcast link on the Dexcom investor relations website at investors.dexcom.com, where it will also be archived.
  • To listen by phone, dial (888) 414-4585 (US/Canada) or (646) 960-0331 (International) and use confirmation ID 9430114 approximately five minutes before the start time.

6ix AI wrote this summary from the release below and checked it against the release.

SAN DIEGO--(BUSINESS WIRE)-- DexCom, Inc. (NASDAQ:DXCM) today announced that it plans to release its third quarter 2026 financial results after market close on Thursday, October 29, 2026. Management will hold a conference call to review the company's third quarter 2026 performance starting at 4:30 p.m. (Eastern Time) on the same day. The conference call will be concurrently webcast. The link to the webcast will be available on the Dexcom investor relations website at investors.dexcom.com and will be archived there for future reference.

To listen to the conference call, please dial (888) 414-4585 (US/Canada) or (646) 960-0331 (International) and use the confirmation ID "9430114" approximately five minutes prior to the start time.

About DexCom, Inc.

Dexcom empowers people to take control of health through innovative biosensing technology. Founded in 1999, Dexcom has pioneered and set the standard in glucose biosensing for more than 25 years. Its technology has transformed how people manage diabetes and track their glucose, helping them feel more in control and live more confidently.

Category: IR

DexCom, Inc.: Sean ChristensenSenior Vice President – Finance and Investor Relations [email protected](858) 200-0200

Source: DexCom, Inc.

View original source (Business Wire)DexCom, Inc. on 6ix

Story so far

Earlier from DexCom

Later from DexCom

All DexCom news releases